CClinicalTrials.gg
CompletedNCT03866889Updated Jan 27, 2020

Guided Training Program of Maximum Strength in Military Personnel

An interventional study of Strength and Normal activity in Military Activity, sponsored by Investigación en Hemofilia y Fisioterapia. Completed at 1 site in Spain. Open to male participants aged 25 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-27.

Sponsored by Investigación en Hemofilia y Fisioterapia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
Male
01

Study summary

Introduction. The members of the Military Emergency Unit must be physically prepared for any type of situation where required, although their strength training does not follow any concrete structure. Structured training of maximum strength aims to increase the recruitment of different types of fibers, and the increase in the size of these.

Objectives: To evaluate the effectiveness of a maximum strength training protocol in lower extremity functionality in military personnel aged 25 to 45 years.

Study design. Randomized, single-blind clinical study with follow-up period. Methodology. 65 male subjects will be recruited, who will be randomly assigned to the two study groups: experimental (structured strength training) and control (they will continue with their usual routine of free training). The intervention will last for 8 weeks, with 2 weekly sessions, lasting 20 minutes, with three evaluations (baseline, posttreatment and follow-up). The study variables will be: lower limb functionality (assessed by Standing Long Jump and Single Leg Hop tests), and quadriceps and hamstring strength (evaluated with the MRI measurement for each exercise). To perform the analysis of normality, the Kolmogorov Smirnof test will be used. In case of homogeneity, with the t-student test of repeated measures and an ANOVA of repeated means, the difference between the different evaluations and the intra and intersubject effect, respectively, will be calculated.

Expected results. Effectiveness of structured training of maximum strength in functionality of lower extremities.

02

Conditions studied

  • Military Activity

Keywords

  • Strength
  • Military
  • Functionality
  • Physiotherapy
  • Randomized clinical trial
03

In context

Lead sponsor

Investigación en Hemofilia y Fisioterapia is the lead sponsor of 54 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Military personnel belonging to the Military Emergency Unit
  • male
  • With an age of 25 to 45 years
  • No history of musculoskeletal injury in the 3 months prior to the study

Exclusion criteria

Exclusion Criteria:

  • Present a diagnosis of injury in the period prior to or during the study
  • Who are receiving a physiotherapy intervention at the time of the study
  • Not signed the informed consent document
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Strength

    Maximum strength protocol based on a Maximum Repetition (1RM). The aim of the application of the training is to produce an increase in strength based on training with high loads (80% 1RM), individually and covering the muscles of the lower extremity (quadriceps, hamstrings, gluteus maximus).

    Other: Strength

  • Active comparator
    Normal activity

    The subjects included in the control group will perform the same physical activity to improve the strenght until the beginning of the study. The exercises will be done in the same conditions and with the same period (4 days / week)

    Other: Normal activity

Interventions

  • OtherStrength

    In the performance of the squat exercise (Back Squat), the subjects will be standing, with an Olympic bar behind their neck, supported on both trapezoids, while the hands will help to hold and stabilize the bar, taking it from below. For hamstring curl, the subject will be in the prone position, clinging to the backrest, with the legs under the arm that lifts the weight. The deadlift exercise will be performed from the standing posture, holding the bar with your arms extended and the trunk straight, while your hands will hold the bar at the height and separation of the hips. Finally, in the quadriceps chair the subject will find himself sitting with his back straight and supported on the back of the seat, while the legs will go under the arm that lifts the weight.

    Also known as: Maximum strength

  • OtherNormal activity

    The subjects included in the control group will continue to perform the same strength training plan that they did before starting this one. The periodicity will be the same (4 days / week) and with the same intensity.

    Also known as: Maximum strength

06

What researchers measure

Primary outcomes

  1. Change from baseline Maximum strength after treatment and at one month

    The RM strength assessment protocol will be used. In the squat you will be asked to bend your knees and hips over ninety degrees, then return to the starting position. In deadlift, you will be asked to take the bar from the height of the hips to just below the label, keeping the trunk upright, facing the front. Both in the quadriceps chair and in the hamstring curl, you will be asked to perform the lifting of the indicated weight, following the movement allowed by the machine to be used. The greater the weight lifted (in kg), the greater muscular strength.

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

Secondary outcomes

  1. Change from baseline lower limb functionality after treatment and at one month

    The assessment of the lower limb functionality will be carried out by Standing Long Jump.In the use of Standing Long Jump, with the subject standing, behind a demarcated line aligns the tips of the feet, a squat will be requested by throwing the arms backwards and ordering the performance of a bipodal jump, with impulse of the extremities inferior ones, helping themselves with the balancing of the superiors. The distance traveled will be measured in centimeters and the test will only be valid when the subject lands with both limbs without losing balance. At greater distance (cm), greater functionality of lower limbs.

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

  2. Change from baseline lower limb functionality after treatment and at one month

    The functionality was measured with the Standing Long Jump test, with the subject standing, behind a demarcated line aligns the tips of the feet. You will be asked to squat by throwing your arms behind you and ordering a bipodal jump, with impulse of the lower limbs being helped by the swing of the upper ones. The distance traveled will be measured in centimeters and the test will only be valid when the subject lands with both limbs without losing balance. The measurement is made from the starting line to the landing point coinciding with the tip of the subject's feet. This test is done in a monopodal way. At greater distance (cm), greater functionality of lower limbs.

    Time frame: Screening visit, within the first seven days after treatment and after one month follow-up visit

07

Study locations

1 site
  • Universidad Europea de Madrid
    Madrid, Comunity Of Madrid 28670, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03866889
Lead sponsor
Investigación en Hemofilia y Fisioterapia
Responsible party
Sponsor
First posted
Mar 7, 2019
Start date
Mar 4, 2019
Primary completion
May 10, 2019
Completion
Jun 15, 2019
Last update
Jan 27, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion